IDEXX Laboratories, Inc. (0J8P.L)
USD 410.47
(2.15%)
USD 410.47
(2.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.21 Billion USD | 22.07% |
| 2022 | 1.01 Billion USD | -3.57% |
| 2021 | 1.03 Billion USD | 34.2% |
| 2020 | 793.8 Million USD | 25.63% |
| 2019 | 643.68 Million USD | 12.52% |
| 2018 | 575.66 Million USD | 18.96% |
| 2017 | 501.42 Million USD | 17.93% |
| 2016 | 431.69 Million USD | 13.67% |
| 2015 | 370.29 Million USD | 18.39% |
| 2014 | 319.8 Million USD | -2.44% |
| 2013 | 322.34 Million USD | 1.6% |
| 2012 | 316.18 Million USD | 11.15% |
| 2011 | 284.74 Million USD | 15.86% |
| 2010 | 250.5 Million USD | 15.86% |
| 2009 | 226.22 Million USD | 2.04% |
| 2008 | 223.59 Million USD | -2.72% |
| 2007 | 177.28 Million USD | 12.49% |
| 2006 | 157.74 Million USD | 13.18% |
| 2005 | 139.7 Million USD | 10.45% |
| 2004 | 126.46 Million USD | 27.12% |
| 2003 | 80.38 Million USD | 15.4% |
| 2002 | 65.81 Million USD | 9.09% |
| 2001 | 78.78 Million USD | 8.32% |
| 2000 | 72.73 Million USD | 13.64% |
| 1999 | 64 Million USD | -15.01% |
| 1998 | 45.1 Million USD | 99.21% |
| 1997 | 10 Million USD | -23.01% |
| 1996 | 57.4 Million USD | 42.32% |
| 1995 | 38.6 Million USD | 26.84% |
| 1994 | 27.3 Million USD | 63.86% |
| 1993 | 17.7 Million USD | 118.42% |
| 1992 | 8.6 Million USD | 171.43% |
| 1991 | 3.6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 297.71 Million USD | -10.11% |
| 2024 Q1 | 333.29 Million USD | 20.83% |
| 2024 Q3 | 207.59 Million USD | 13.72% |
| 2023 Q1 | 280.39 Million USD | 23.78% |
| 2023 FY | - USD | 22.07% |
| 2023 Q4 | 245.3 Million USD | -10.89% |
| 2023 Q3 | 275.28 Million USD | -7.04% |
| 2023 Q2 | 296.14 Million USD | 5.62% |
| 2022 Q1 | 274.99 Million USD | 38.06% |
| 2022 Q3 | 273.72 Million USD | 52.86% |
| 2022 Q2 | 179.06 Million USD | -34.88% |
| 2022 Q4 | 226.52 Million USD | -17.24% |
| 2022 FY | - USD | -3.57% |
| 2021 Q3 | 252.55 Million USD | -2.59% |
| 2021 Q1 | 272.73 Million USD | 47.35% |
| 2021 Q2 | 259.25 Million USD | -4.94% |
| 2021 Q4 | 199.19 Million USD | -21.13% |
| 2021 FY | - USD | 34.2% |
| 2020 Q1 | 167.66 Million USD | 45.0% |
| 2020 FY | - USD | 25.63% |
| 2020 Q2 | 216.89 Million USD | 29.36% |
| 2020 Q3 | 196.71 Million USD | -9.31% |
| 2020 Q4 | 185.09 Million USD | -5.91% |
| 2019 FY | - USD | 12.52% |
| 2019 Q1 | 154.53 Million USD | 33.97% |
| 2019 Q3 | 162.33 Million USD | -12.69% |
| 2019 Q2 | 185.92 Million USD | 20.32% |
| 2019 Q4 | 115.63 Million USD | -28.77% |
| 2018 Q2 | 166.65 Million USD | 23.98% |
| 2018 Q1 | 134.42 Million USD | 37.44% |
| 2018 Q3 | 138.37 Million USD | -16.97% |
| 2018 FY | - USD | 18.96% |
| 2018 Q4 | 115.34 Million USD | -16.64% |
| 2017 Q3 | 122.54 Million USD | -15.09% |
| 2017 FY | - USD | 17.93% |
| 2017 Q4 | 97.8 Million USD | -20.18% |
| 2017 Q2 | 144.32 Million USD | 27.01% |
| 2017 Q1 | 113.63 Million USD | 35.56% |
| 2016 Q4 | 83.82 Million USD | -23.15% |
| 2016 Q2 | 124.75 Million USD | 33.92% |
| 2016 Q3 | 109.07 Million USD | -12.57% |
| 2016 Q1 | 93.15 Million USD | 39.23% |
| 2016 FY | - USD | 13.67% |
| 2015 Q1 | 72.8 Million USD | 109.2% |
| 2015 Q4 | 66.91 Million USD | -32.46% |
| 2015 Q3 | 99.07 Million USD | -6.23% |
| 2015 Q2 | 105.65 Million USD | 45.12% |
| 2015 FY | - USD | 18.39% |
| 2014 Q1 | 83.91 Million USD | 36.82% |
| 2014 FY | - USD | -2.44% |
| 2014 Q4 | 34.8 Million USD | -60.46% |
| 2014 Q3 | 88.02 Million USD | -10.55% |
| 2014 Q2 | 98.4 Million USD | 17.27% |
| 2013 Q2 | 78.76 Million USD | 4.81% |
| 2013 Q4 | 61.32 Million USD | -23.06% |
| 2013 Q3 | 79.71 Million USD | 1.21% |
| 2013 FY | - USD | 1.6% |
| 2013 Q1 | 75.14 Million USD | 18.47% |
| 2012 Q3 | 76.18 Million USD | 0.48% |
| 2012 Q4 | 63.42 Million USD | -16.74% |
| 2012 Q1 | 60.4 Million USD | -11.97% |
| 2012 FY | - USD | 11.15% |
| 2012 Q2 | 75.81 Million USD | 25.51% |
| 2011 Q1 | 65.36 Million USD | 3.79% |
| 2011 Q2 | 83.59 Million USD | 27.89% |
| 2011 FY | - USD | 15.86% |
| 2011 Q4 | 68.61 Million USD | 0.04% |
| 2011 Q3 | 68.59 Million USD | -17.95% |
| 2010 Q1 | 59.72 Million USD | 5.08% |
| 2010 Q2 | 66.35 Million USD | 11.1% |
| 2010 Q4 | 62.97 Million USD | 2.51% |
| 2010 Q3 | 61.43 Million USD | -7.42% |
| 2010 FY | - USD | 15.86% |
| 2009 FY | - USD | 2.04% |
| 2009 Q2 | 49.17 Million USD | -4.94% |
| 2009 Q4 | 56.84 Million USD | 0.14% |
| 2009 Q3 | 56.75 Million USD | 15.42% |
| 2009 Q1 | 51.73 Million USD | 1.8% |
| 2008 Q2 | 71.47 Million USD | 42.63% |
| 2008 Q4 | 50.81 Million USD | -0.72% |
| 2008 FY | - USD | -2.72% |
| 2008 Q1 | 50.11 Million USD | 3.75% |
| 2008 Q3 | 51.18 Million USD | -28.39% |
| 2007 FY | - USD | 12.49% |
| 2007 Q4 | 48.3 Million USD | 4.18% |
| 2007 Q3 | 46.36 Million USD | 8.6% |
| 2007 Q2 | 42.69 Million USD | 6.93% |
| 2007 Q1 | 39.92 Million USD | 6.33% |
| 2006 Q2 | 44.53 Million USD | 32.87% |
| 2006 Q1 | 33.52 Million USD | -8.07% |
| 2006 FY | - USD | 13.18% |
| 2006 Q4 | 37.54 Million USD | -10.58% |
| 2006 Q3 | 41.99 Million USD | -5.72% |
| 2005 FY | - USD | 10.45% |
| 2005 Q3 | 36.26 Million USD | 3.86% |
| 2005 Q1 | 31.85 Million USD | 11.72% |
| 2005 Q4 | 36.46 Million USD | 0.55% |
| 2005 Q2 | 34.91 Million USD | 9.61% |
| 2004 Q2 | 34.73 Million USD | 17.8% |
| 2004 Q4 | 28.51 Million USD | -14.97% |
| 2004 FY | - USD | 27.12% |
| 2004 Q1 | 29.48 Million USD | 47.71% |
| 2004 Q3 | 33.53 Million USD | -3.45% |
| 2003 Q4 | 19.96 Million USD | -27.94% |
| 2003 Q2 | 24.33 Million USD | 30.9% |
| 2003 FY | - USD | 15.4% |
| 2003 Q1 | 17.44 Million USD | -3.89% |
| 2003 Q3 | 23.28 Million USD | -5.36% |
| 2002 FY | - USD | 9.09% |
| 2002 Q3 | 23.97 Million USD | 1.15% |
| 2002 Q1 | 15.56 Million USD | -28.28% |
| 2002 Q4 | 23.26 Million USD | -2.99% |
| 2002 Q2 | 23.7 Million USD | 52.36% |
| 2001 Q4 | 21.69 Million USD | 5.67% |
| 2001 FY | - USD | 8.32% |
| 2001 Q1 | 21.48 Million USD | 8.91% |
| 2001 Q2 | 15.04 Million USD | -5.89% |
| 2001 Q3 | 15.44 Million USD | 1.52% |
| 2000 Q4 | 19.72 Million USD | 8.16% |
| 2000 FY | - USD | 13.64% |
| 2000 Q3 | 18.24 Million USD | -2.58% |
| 2000 Q2 | 18.72 Million USD | 16.75% |
| 2000 Q1 | 16.03 Million USD | -6.76% |
| 1999 Q4 | 17.2 Million USD | 5.52% |
| 1999 FY | - USD | -15.01% |
| 1999 Q2 | 15.8 Million USD | 9.02% |
| 1999 Q1 | 14.6 Million USD | -73.29% |
| 1999 Q3 | 16.3 Million USD | 12.41% |
| 1998 FY | - USD | 99.21% |
| 1998 Q4 | 14.2 Million USD | 413.4% |
| 1998 Q3 | 11.7 Million USD | 16.87% |
| 1998 Q2 | 10 Million USD | 9.21% |
| 1998 Q1 | 9.2 Million USD | -3.8% |
| 1997 Q2 | -1.4 Million USD | -487.5% |
| 1997 Q1 | 2.6 Million USD | -94.67% |
| 1997 FY | - USD | -23.01% |
| 1997 Q4 | 3 Million USD | -75.39% |
| 1997 Q3 | 5.7 Million USD | 1135.48% |
| 1996 Q3 | 16.2 Million USD | 41.18% |
| 1996 Q2 | 12.5 Million USD | 8.51% |
| 1996 Q1 | 11.7 Million USD | 9.3% |
| 1996 FY | - USD | 42.32% |
| 1996 Q4 | 17 Million USD | 4.17% |
| 1995 Q1 | 7.5 Million USD | -25.81% |
| 1995 FY | - USD | 26.84% |
| 1995 Q4 | 11.1 Million USD | -15.69% |
| 1995 Q2 | 9.5 Million USD | 28.99% |
| 1995 Q3 | 10.6 Million USD | 14.61% |
| 1994 Q4 | 8.4 Million USD | 45.31% |
| 1994 Q2 | 6.6 Million USD | 21.57% |
| 1994 Q3 | 6.8 Million USD | 3.23% |
| 1994 FY | - USD | 63.86% |
| 1994 Q1 | 5.4 Million USD | -16.39% |
| 1993 Q2 | 4 Million USD | 42.31% |
| 1993 FY | - USD | 118.42% |
| 1993 Q4 | 6.4 Million USD | 38.64% |
| 1993 Q1 | 2.8 Million USD | 23.81% |
| 1993 Q3 | 4.7 Million USD | 18.92% |
| 1992 Q3 | 2.6 Million USD | 9.52% |
| 1992 Q2 | 2.4 Million USD | 61.54% |
| 1992 Q1 | 1.4 Million USD | -60.61% |
| 1992 Q4 | 2.3 Million USD | -8.7% |
| 1992 FY | - USD | 171.43% |
| 1991 Q3 | 900 Thousand USD | -166.67% |
| 1991 FY | - USD | 0.0% |
| 1991 Q1 | 6.3 Million USD | 0.0% |
| 1991 Q4 | 1.6 Million USD | 925.0% |
| 1991 Q2 | 700 Thousand USD | -90.48% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 1282.831% |
| Accuray Incorporated | 9 Million USD | -13416.095% |
| Align Technology, Inc. | 799.03 Million USD | -52.391% |
| Elevance Health Inc. | 10.49 Billion USD | 88.392% |
| AxoGen, Inc. | -13.32 Million USD | 9236.142% |
| Boston Scientific Corporation | 3.61 Billion USD | 66.298% |
| CVS Health Corporation | 18.17 Billion USD | 93.301% |
| Cardinal Health, Inc. | 1.97 Billion USD | 38.44% |
| Centene Corporation | -463 Million USD | 362.995% |
| DaVita Inc. | 2.34 Billion USD | 48.106% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 90.428% |
| Hologic, Inc. | 1.29 Billion USD | 6.059% |
| Humana Inc. | -561 Million USD | 317.053% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 9.762% |
| Masimo Corporation | 236.7 Million USD | -414.434% |
| McKesson Corporation | 4.66 Billion USD | 73.909% |
| Patterson Companies, Inc. | 374.75 Million USD | -224.922% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 29.696% |
| ResMed Inc. | 1.6 Billion USD | 23.912% |
| Henry Schein, Inc. | 943 Million USD | -29.127% |
| Teladoc Health, Inc. | 153.99 Million USD | -690.707% |
| Universal Health Services, Inc. | 1.74 Billion USD | 30.157% |
| Veeva Systems Inc. | 429.33 Million USD | -183.617% |
| Baxter International Inc. | 2.77 Billion USD | 56.136% |
| Becton, Dickinson and Company | 4.27 Billion USD | 71.517% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 49.139% |
| Danaher Corporation | 7.49 Billion USD | 83.762% |
| Stryker Corporation | 5.16 Billion USD | 76.402% |
| Medtronic plc | 9.05 Billion USD | 86.554% |